This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, J. R.
Right arrow Articles by Raz, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, J. R.
Right arrow Articles by Raz, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2005, p. 4739-4744, Vol. 49, No. 11
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.11.4739-4744.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Spontaneous Conversion to Quinolone and Fluoroquinolone Resistance among Wild-Type Escherichia coli Isolates in Relation to Phylogenetic Background and Virulence Genotype

James R. Johnson,1,2* Brian Johnston,1,2 Michael A. Kuskowski,3,4 Raul Colodner,5 and Raul Raz6,7

Medical Service,1 Geriatric Research, Education, and Clinical Center, VA Medical Center, Minneapolis, Minnesota,2 Departments of Medicine,3 Psychiatry, University of Minnesota, Minneapolis, Minnesota,4 Microbiology Laboratory,5 Infectious Diseases Unit, HaEmek Medical Center, Afula, Israel,6 Technion School of Medicine, Afula, Israel7

Received 17 June 2005/ Returned for modification 1 August 2005/ Accepted 23 August 2005

Human clinical isolates of Escherichia coli that are resistant to quinolone or fluoroquinolone agents typically exhibit fewer extraintestinal virulence factors (VFs) than susceptible isolates, along with a different phylogenetic background. To experimentally assess the basis for this as-yet-unexplained phenomenon, 40 E. coli strains (20 E. coli Reference collection members and 20 Israeli cystitis isolates) were subjected to serial selective passaging to obtain derivatives resistant to nalidixic acid (NA) and ciprofloxacin (C). PCR-based VF profiling and phylotyping were performed on the parents and their respective resistant derivatives. All 40 susceptible parent strains yielded NA- and C-resistant derivatives after a median of 6 (range, 4 to 12) serial selective passages on agar plates containing increasing concentrations of NA and C. The numbers of passages required for resistance did not differ by collection origin, phylogenetic group, basal VF profile, source (urine versus fecal), or host group (human versus animal). With the development of C resistance, only one VF was lost in a single strain. Resistant derivatives exhibited the same phylotype as their susceptible parents. These findings suggest that the sparse VF profiles and the low-virulence phylogenetic background of NA- and C-resistant E. coli clinical isolates probably are not attributable to the loss of VFs from intrinsically high-virulence strains during conversion to resistance or to enhanced emergence of drug resistance among intrinsically low-virulence strains. A more likely explanation is the importation of resistant strains from an as-yet-undefined low-virulence external selection reservoir.


* Corresponding author. Mailing address: Infectious Diseases (111F), Minneapolis VA Medical Center, 1 Veterans Drive, Minneapolis, MN 55417. Phone: (612) 467-4185. Fax: (612) 727-5995. E-mail: johns007{at}umn.edu.


Antimicrobial Agents and Chemotherapy, November 2005, p. 4739-4744, Vol. 49, No. 11
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.11.4739-4744.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Petkovsek, Z., Elersic, K., Gubina, M., Zgur-Bertok, D., Starcic Erjavec, M. (2009). Virulence Potential of Escherichia coli Isolates from Skin and Soft Tissue Infections. J. Clin. Microbiol. 47: 1811-1817 [Abstract] [Full Text]  
  • Deschamps, C., Clermont, O., Hipeaux, M. C., Arlet, G., Denamur, E., Branger, C. (2009). Multiple acquisitions of CTX-M plasmids in the rare D2 genotype of Escherichia coli provide evidence for convergent evolution. Microbiology 155: 1656-1668 [Abstract] [Full Text]  
  • Piatti, G., Mannini, A., Balistreri, M., Schito, A. M. (2008). Virulence Factors in Urinary Escherichia coli Strains: Phylogenetic Background and Quinolone and Fluoroquinolone Resistance. J. Clin. Microbiol. 46: 480-487 [Abstract] [Full Text]  
  • Corvec, S., Prodhomme, A., Giraudeau, C., Dauvergne, S., Reynaud, A., Caroff, N. (2007). Most Escherichia coli strains overproducing chromosomal AmpC {beta}-lactamase belong to phylogenetic group A. J Antimicrob Chemother 60: 872-876 [Abstract] [Full Text]  
  • Houdouin, V., Bonacorsi, S., Bidet, P., Bingen-Bidois, M., Barraud, D., Bingen, E. (2006). Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates. J Antimicrob Chemother 58: 748-751 [Abstract] [Full Text]  
  • Johnson, J. R., Drews, S. J., Mazzulli, T., Low, D. E. (2005). Virulence Factors in Escherichia coli. J. Clin. Microbiol. 43: 6221-6222 [Full Text]